Dodolan perusahaan IO Biotech Inc (IOBT)

IO Biotech, Inc. (IOBT) is implementing ESG principles by minimizing chemical damage during the development of immuno-oncology agents. The company's sales volume trajectory clearly demonstrates revenue dynamics, with the current figure recorded at 0.00. The brand is valued in the US and Denmark for the development of metastasis vaccines, and the project's market success relies on the scientific superiority of the data over its counterparts.

iobiotech.com (IOBT): Pendapatan perusahaan saka 04.07.2022 nganti 18.04.2026

Rincian analitis perusahaan IO Biotech (IOBT)

- nilai saham lan prakiraan konsensus rega:

Kutipan saham IO Biotech Inc.|IOBT - Bagan rega target

- rincian kapitalisasi pasar:

Biji pasar IO Biotech, Inc.|IOBT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Buku saben Saham IO Biotech|IOBT - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku iobiotech.com|IOBT - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Modal IO Biotech, Inc.|IOBT - Rasio utang jangka dawa marang ekuitas|Tanggungan utang jangka cendhak marang ekuitas IO Biotech Inc|IOBT - Gunggung utang perusahaan|Utang marang modal buku IO Biotech, Inc.|IOBT - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan IO Biotech|Likuiditas darurat iobiotech.com

- data bathi resik lan rasio valuasi:

IOBT - Bathi resik perusahaan|Penghasilan resik sing dikarepake IO Biotech, Inc.|IOBT - Pangali P/E|Pangali Forward P/E iobiotech.com|IOBT - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan IO Biotech, Inc.|IOBT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan IO Biotech|IOBT - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan iobiotech.com|IOBT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep IO Biotech, Inc.

- indikator volume dodolan lan pendapatan:

IOBT - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan IO Biotech Inc.|IOBT - Multiplikator P/S|Rasio rega marang prakiraan pendapatan IO Biotech, Inc.

Analisis umum perusahaan:IO Biotech Inc., IOBT

Sales for IO Biotech, Inc. (IOBT) capture the actual real-time cash inflow from product sales. This metric measures operational liquidity, revealing hidden imbalances within the capital structure. Analyzing the company's gross sales volume allows for an assessment of the business's current financial stability. This indicator is critical for IO Biotech, Inc. (IOBT), as the company is currently in a loss-making R&D stage. Revenue stability determines the developer's ability to fund vaccine clinical trials without the emergency procurement of external capital.

Pesaing wigati